Conversations in Healthcare

EXPLORE

Society & Culture

© 2024 PodJoint

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/c2/4b/46/c24b4666-10b4-d833-a4ad-77be49cd1422/mza_18369175361314418871.jpeg/600x600bb.jpg

Conversations in Healthcare

Clarivate

48 episodes

9 months ago

Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more.

Hosted on Acast. See acast.com/privacy for more information.

Show more...

All content for Conversations in Healthcare is the property of Clarivate and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more.

Hosted on Acast. See acast.com/privacy for more information.

Show more...

Episodes (20/48)

Conversations in Healthcare

Lighting the touch paper for next generation nucleic acid therapies

In this episode Mike Ward, Clarivate’s Head of Thought Leadership for Life sciences and healthcare, spoke to Johnny Ohlson, Founder of Touchlight, a company who has developed a novel synthetic DNA vector. In recent years, we've seen that by harnessing the power of DNA, it has been possible to achieve success in treating previously incurable hereditary diseases and even tackle major pandemics. However, whether the answer is cell or gene therapies or RNA vaccines, one thing they all have in common is that they require DNA in some form or another as the starting material. Through Touchlight, Johnny Ohlson and his talented team have built a business that can make DNA at unprecedented speed, scale and purity. Johnny, a serial entrepreneur not originally from a biopharma background, shares with us his story of breaking successfully into a complex industry. This podcast demonstrates that innovation at its heart is more about a combination of vision, relationships and talented people rather than prior experience.

Hosted on Acast. See acast.com/privacy for more information.

2 years ago

32 minutes 6 seconds

Conversations in Healthcare

Realizing the patient-friendly future of clinical trials

In this episode of Conversations in Healthcare, Ergomed founder Dr. Miroslav Reljanović talks to Mike Ward about how the COVID-19 pandemic has nudged clinical trials towards greater efficiency and inclusivity – and what’s needed to make good on this promising trend.

Hosted on Acast. See acast.com/privacy for more information.

3 years ago

23 minutes 2 seconds

Conversations in Healthcare

How Patient Connect addresses unmet needs at the point of care

In this episode of Conversations in Healthcare, Mike Ward speaks with Dr. Grace Lomax, Clinical Director at Patient Connect, a part of Clarivate. Grace’s experience as a physician highlighted numerous unmet needs beyond just clinical issues – especially around healthcare literacy, education at the point of care, adherence and more. She discusses how Patient Connect uses technology and communication strategies to inform and support patients at the point of care, and shares examples of campaigns that improved outcomes in cancer, hypertension, rare disease and asthma.

Hosted on Acast. See acast.com/privacy for more information.

3 years ago

22 minutes 32 seconds

Conversations in Healthcare

Social determinants: barriers to healthcare impacting racial and ethnic minorities

In this episode of Conversations in Healthcare, Matthew Arnold, Principal Analyst at Clarivate speaks with Dr. Kenton Johnston, Associate Professor of Health Management and Policy at Saint Louis University about disparities in the US health system. Matthew and Ken discuss both the historical context as well as the evolution of the system since the establishment of the Affordable Care Act, and how the entire spectrum of the healthcare system can work to address social determinants of health. Learn more in the full episode.

Hosted on Acast. See acast.com/privacy for more information.

3 years ago

45 minutes 59 seconds

Conversations in Healthcare

How Novo Ventures prioritized their investment strategy during the pandemic

In this episode of Conversations in Healthcare, Mike Ward speaks with Naveed Saddiqi, Senior Partner at Novo Ventures, one of the largest venture capital groups in the life sciences sector. Naveed shares about the firm’s mandate to generate funds for the Novo Nordisk Foundation, how the pandemic impacted their investment strategy and what excites him most in the life sciences industry. Learn more in the full episode, which was recorded in collaboration with One Nucleus's ON Helix conference (June 2021).

Hosted on Acast. See acast.com/privacy for more information.

3 years ago

25 minutes 50 seconds

Conversations in Healthcare

How Healx uses AI to transform rare disease drug discovery

In this episode of Conversations in Healthcare, Mike Ward speaks with Dr. Tim Guilliams, the co-founder and CEO of Healx. Healx is an artificial intelligence-powered technology company that's dedicated to helping rare disease patients access life improving treatments. Mike and Tim discuss the company’s innovative approach to drug discovery, choosing which rare diseases to target and how patients are shaping their priorities. Learn more in the full episode, which was recorded in collaboration with One Nucleus's ON Helix conference (June 2021).

Hosted on Acast. See acast.com/privacy for more information.

3 years ago

27 minutes 52 seconds

Conversations in Healthcare

How the pandemic shifted Roche’s priorities and R&D investments

In this episode of Conversations in Healthcare, Mike Ward speaks with Richard Erwin, general manager and managing director of Roche Products Limited (UK), which was recorded in collaboration with One Nucleus's ON Helix conference (June 2021). Richard shares how the pandemic has shifted Roche’s priorities and why the organization has heavily increased their investment in R&D. Learn more in the full episode.

Hosted on Acast. See acast.com/privacy for more information.

3 years ago

31 minutes 20 seconds

Conversations in Healthcare

Optimizing patient-first clinical trials with advanced site intelligence

In this episode of Conversations in Healthcare, Mike Ward speaks with Oriol Serra, former Head of Site Intelligence and Selection at Pfizer and Simon Andrews, Vice President of RWD Engagements and Innovations at Clarivate about optimizing patient-first clinical trial design and ensuring trial groups align to real-life populations and needs.

The group discusses the ins and outs to bring clinical trial management in-house, how to modernize trial designs with emerging data and intelligence, overcoming key challenges and advice for other pharma and biotechs looking to go down this path. Learn more in the full episode.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

40 minutes 56 seconds

Conversations in Healthcare

Showing the value of regulatory intelligence in pharma

In this episode of Conversations in Healthcare, Mike Ward speaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca, and Céline Rodier, Senior Health Policy Manager at Clarivate, about strategies and tools to gather and assess regulatory intelligence, as well as KPIs and approaches to demonstrating ROI within your organization. Get actionable takeaways in the full episode.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

31 minutes 32 seconds

Conversations in Healthcare

Overcoming health inequity in the U.S. and the role of telehealth: Ideas and best practices from Cigna, Henry Ford Health System and the eHealth Initiative

Increased reliance on telehealth services has been one of the most significant care delivery shifts prompted by the COVID-19 pandemic. However, the pandemic has also thrown more light on the challenges of health inequity in the United States, especially among African American and Hispanic communities. We discuss these issues and potential solutions with leaders at the eHealth Initiative, Cigna and Henry Ford Health System.

Panelists include:

Wanneh Dixon, who is Director of Programs, Strategy & Development at eHealth Initiative
Will M. Lopez, the National Medical Director-Virtual Care and Senior Medical Director-Behavioral Health at Cigna; and
Denise White-Perkins, who is not only the Vice Chair of Academic Affairs, Associate Residency Program Director, Department of Family Medicine, and Director, Healthcare Equity Initiatives, Office of System Diversity Equity and Inclusion at Henry Ford Health System but is also Clinical Associate Professor, at Wayne State University School of Medicine, Department of Family Medicine and Public Health Sciences

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

36 minutes 46 seconds

Conversations in Healthcare

Best practices for university - healthcare partnerships: Learnings from the Institute of Cancer Research

In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Dr. Toby Richardson, who is Head of Business Development and Licensing; Deputy Director of Business and Innovation at The Institute of Cancer Research. Mike and Toby discuss how research collaborations between the ICR and biopharma companies help the Institute achieve its mission to make the discoveries that defeat cancer. Learn more in the full episode.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

27 minutes 59 seconds

Conversations in Healthcare

Best practices for university – healthcare partnerships: Learnings from Oxford

In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Dr. Phil Clare, the Deputy Director, Research Services (Knowledge Exchange and Engagement) at the University of Oxford. Mike and Dr. Clare discuss the key role that university research plays in shaping new medicines and technologies, and what that process looks like. Learn more in the full episode.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

35 minutes 15 seconds

Conversations in Healthcare

The evolution of the asset-centric approach in biotech venture capital

In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Francesco De Rubertis, a co-founder and managing partner at Medicxi, one of the most prominent financial supporters of innovative biotech activity. Francesco provides insights into how the biotech venture capital model has evolved in the past decades to an asset-centric approach, and discusses Centessa, which recently secured $250m in funding. Learn more in the full episode.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

47 minutes 29 seconds

Conversations in Healthcare

Drugs to Watch 2021

Clarivate market experts break down the opportunities and potential threats for 2021’s Drugs to Watch – the key drugs expected to be blockbusters by 2026.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

23 minutes 50 seconds

Conversations in Healthcare

Transforming the treatment of cancer with oncolytic viruses

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, speaks with Stephen Russell, CEO of Vyriad. Dr. Russell reveals invaluable insights for those looking for or currently putting together partnership deals. Stephen shares his journey from academia at the Mayo Clinic to founding Vyriad, and eventually partnering with Regeneron for the development of new oncolytic virus treatments for cancer. Learn how Vyriad pivoted their technology to develop antibody tests for COVID-19 during the crisis.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

33 minutes 6 seconds

Conversations in Healthcare

The past, present and future of next generation sequencing

In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Nick McCooke, CEO of Longas Technologies. Having been at the forefront of developing next generation sequencing, Nick talks to Mike about his past work, current projects and future predictions for this key technology in the life sciences space. He explains the process and journey he went on to trigger the creation of Solexa, which was later acquired by Illumina, and how next generation sequencing developed and transformed the marketplace after this acquisition. Nick also explains the role NGS has played in the development of Covid-19 solutions around the world, including mapping the viral genome and tracking subsequent mutations. They go onto the discuss the long-read sequencing platform Longas Technologies is currently working on and how this could advance NGS even. Nick also gives his predictions on where NGS could go next, and how it’ll continue to develop and benefit the patient.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

30 minutes 7 seconds

Conversations in Healthcare

A novel approach to treating neurodegenerative disease

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Dr. Leen Kawas, president and CEO of Athira Pharma. Dr. Kawas shares the company’s innovative approach to treating Alzheimer’s disease by developing small molecules to restore neuronal health and stop neurodegeneration. They also discuss Athira’s recent IPO following a successful series B funding round, all during the pandemic.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

26 minutes 19 seconds

Conversations in Healthcare

COVID-19, multi-stem clinical trials and a new way of fundraising

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Gil Van Bokkelen, founder, chairman and CEO of Athersys Inc. They discuss the company’s clinical program that is focusing on a special class of stem cells which display very unique properties and have been obtained from healthy young consenting donors. Mike and Gil talk about how Athersys was already working on an approach to treat patients with acute respiratory distress syndrome before the pandemic emerged and the challenges they face to tackle their COVID-19 strategy. Also, Gil shares how Athersys was successful in raising nearly $58m in April and what he thinks the company needs to do to become a multibillion-dollar company.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

50 minutes 5 seconds

Conversations in Healthcare

Early planning key to successful access and product launch

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, speaks with Alison Kneen, Senior Vice President, Global Market Access and Head of the Centre of Innovation and Regulatory Science (CIRS) and DRG Abacus. Learn why early and thorough planning is so important for a successful product launch, and how Alison and her team helped one client avoid major pitfalls, even when the odds were stacked against them.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

29 minutes 35 seconds

Conversations in Healthcare

Pivoting a product launch during the pandemic

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Bryan Witherbee, President & CEO of Adarza BioSystems. Earlier this year, Adarza raised 25 million dollars to support the full commercialization of Ziva, an automated biological platform which delivers comprehensive, high definition, protein biomarker profiles. Although their launch plans were disrupted by the pandemic, Bryan shares how Adarza responded to the challenge by utilizing Ziva for COVID-19 research.

Hosted on Acast. See acast.com/privacy for more information.

4 years ago

35 minutes 23 seconds